Evidence map›Paper›PMID 42711328›Full record

ArticleNature communications2026

Segment any tumour: an uncertainty-aware vision foundation model for whole-body analysis.

Himashi Peiris, Sizhe Wang, Gary Egan, Mehrtash Harandi, Meng Law, Zhaolin Chen

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Himashi PeirisDepartment of Data Science & Artificial Intelligence, Faculty of Information Technology, Monash University, Melbourne, VIC, Australia.
Sizhe WangDepartment of Data Science & Artificial Intelligence, Faculty of Information Technology, Monash University, Melbourne, VIC, Australia.
Gary EganMonash Biomedical Imaging (MBI), Monash University, Melbourne, VIC, Australia.
Mehrtash HarandiDepartment of Electrical & Computer Systems Engineering, Faculty of Engineering, Monash University, Melbourne, VIC, Australia.
Meng LawDepartment of Neuroscience, The School of Translational Medicine, Monash University, Melbourne, VIC, Australia.
Zhaolin ChenDepartment of Data Science & Artificial Intelligence, Faculty of Information Technology, Monash University, Melbourne, VIC, Australia. Zhaolin.Chen@monash.edu.ORCID 0000-0002-0173-6090

Funding

Department of Education and Training | Australian Research Council (ARC) DP210101863Department of Education and Training | Australian Research Council (ARC) IM230100002
6 · The paper itself

Abstract

Prompt-driven vision foundation models, such as the Segment Anything Model, have shown adaptability in computer vision, but their use in medical imaging remains challenging due to heterogeneous anatomy, artefacts, and low-contrast tumour boundaries. This is particularly difficult in whole-body tumour analysis, where models must transfer across modalities, anatomies, and tumour appearances. Here, we present Segment Any Tumour 3D (SAT3D), a lightweight volumetric foundation model for generalisable tumour segmentation across diverse medical imaging modalities, organs, and cohorts. SAT3D integrates a shifted-window vision transformer with critic-guided uncertainty-aware training, using confidence maps as dense prompts to guide boundary prediction in ambiguous regions. We benchmark SAT3D against vision foundation models, prompt-driven and task-specific methods across 11 public datasets. Trained on 17,075 three-dimensional volume-mask pairs, SAT3D shows robust generalisation, including in out-of-distribution settings, and is supported by a 3D-Slicer plugin for interactive segmentation, underscoring SAT3D's potential as a scalable foundation model for medical image analysis.

Indexed as

Imaging, Three-DimensionalNeoplasmsWhole Body ImagingAlgorithmsHumansUncertainty

Identifiers

PMID42711328
PMCPMC13554230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.